ReviewDrug safety2007
Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.
Daniel De BackerPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewDrug safety2007
Daniel De BackerPubMed ↗Publisher ↗
No numbers read from the abstract.